464 related articles for article (PubMed ID: 29222693)
21. Neuroblastoma: molecular pathogenesis and therapy.
Louis CU; Shohet JM
Annu Rev Med; 2015; 66():49-63. PubMed ID: 25386934
[TBL] [Abstract][Full Text] [Related]
22. Revealed: The spy who regulates neuroblastoma stem cells.
Vora P; Venugopal C; Singh SK
Oncotarget; 2014 Nov; 5(22):11014-6. PubMed ID: 25483101
[TBL] [Abstract][Full Text] [Related]
23. Prokineticin signaling is required for the maintenance of a de novo population of c-KIT⁺ cells to sustain neuroblastoma progression.
Lau ST; Hansford LM; Chan WK; Chan GC; Wan TS; Wong KK; Kaplan DR; Tam PK; Ngan ES
Oncogene; 2015 Feb; 34(8):1019-34. PubMed ID: 24632619
[TBL] [Abstract][Full Text] [Related]
24. TRPM7 maintains progenitor-like features of neuroblastoma cells: implications for metastasis formation.
Middelbeek J; Visser D; Henneman L; Kamermans A; Kuipers AJ; Hoogerbrugge PM; Jalink K; van Leeuwen FN
Oncotarget; 2015 Apr; 6(11):8760-76. PubMed ID: 25797249
[TBL] [Abstract][Full Text] [Related]
25. β-Carotene 15,15'-oxygenase inhibits cancer cell stemness and metastasis by regulating differentiation-related miRNAs in human neuroblastoma.
Kim YS; Gong X; Rubin LP; Choi SW; Kim Y
J Nutr Biochem; 2019 Jul; 69():31-43. PubMed ID: 31048207
[TBL] [Abstract][Full Text] [Related]
26. Environmental cues from neural crest derivatives act as metastatic triggers in an embryonic neuroblastoma model.
Ben Amar D; Thoinet K; Villalard B; Imbaud O; Costechareyre C; Jarrosson L; Reynaud F; Novion Ducassou J; Couté Y; Brunet JF; Combaret V; Corradini N; Delloye-Bourgeois C; Castellani V
Nat Commun; 2022 May; 13(1):2549. PubMed ID: 35538114
[TBL] [Abstract][Full Text] [Related]
27. Neural crest development and neuroblastoma: the genetic and biological link.
Nakagawara A
Prog Brain Res; 2004; 146():233-42. PubMed ID: 14699967
[TBL] [Abstract][Full Text] [Related]
28. MYCN induces neuroblastoma in primary neural crest cells.
Olsen RR; Otero JH; García-López J; Wallace K; Finkelstein D; Rehg JE; Yin Z; Wang YD; Freeman KW
Oncogene; 2017 Aug; 36(35):5075-5082. PubMed ID: 28459463
[TBL] [Abstract][Full Text] [Related]
29. Role of stemness-related molecules in neuroblastoma.
Kamijo T
Pediatr Res; 2012 Apr; 71(4 Pt 2):511-5. PubMed ID: 22430387
[TBL] [Abstract][Full Text] [Related]
30. G-CSF Promotes Neuroblastoma Tumorigenicity and Metastasis via STAT3-Dependent Cancer Stem Cell Activation.
Agarwal S; Lakoma A; Chen Z; Hicks J; Metelitsa LS; Kim ES; Shohet JM
Cancer Res; 2015 Jun; 75(12):2566-79. PubMed ID: 25908586
[TBL] [Abstract][Full Text] [Related]
31. Neuroblastoma cells isolated from bone marrow metastases contain a naturally enriched tumor-initiating cell.
Hansford LM; McKee AE; Zhang L; George RE; Gerstle JT; Thorner PS; Smith KM; Look AT; Yeger H; Miller FD; Irwin MS; Thiele CJ; Kaplan DR
Cancer Res; 2007 Dec; 67(23):11234-43. PubMed ID: 18056449
[TBL] [Abstract][Full Text] [Related]
32. Small molecule kinase inhibitor screen identifies polo-like kinase 1 as a target for neuroblastoma tumor-initiating cells.
Grinshtein N; Datti A; Fujitani M; Uehling D; Prakesch M; Isaac M; Irwin MS; Wrana JL; Al-Awar R; Kaplan DR
Cancer Res; 2011 Feb; 71(4):1385-95. PubMed ID: 21303981
[TBL] [Abstract][Full Text] [Related]
33. The neural crest: a versatile organ system.
Zhang D; Ighaniyan S; Stathopoulos L; Rollo B; Landman K; Hutson J; Newgreen D
Birth Defects Res C Embryo Today; 2014 Sep; 102(3):275-98. PubMed ID: 25227568
[TBL] [Abstract][Full Text] [Related]
34. Investigational drugs in phase II clinical trials for the treatment of neuroblastoma.
Amoroso L; Haupt R; Garaventa A; Ponzoni M
Expert Opin Investig Drugs; 2017 Nov; 26(11):1281-1293. PubMed ID: 28906153
[TBL] [Abstract][Full Text] [Related]
35. Neuroblastoma: Emerging trends in pathogenesis, diagnosis, and therapeutic targets.
Katta SS; Nagati V; Paturi ASV; Murakonda SP; Murakonda AB; Pandey MK; Gupta SC; Pasupulati AK; Challagundla KB
J Control Release; 2023 May; 357():444-459. PubMed ID: 37023798
[TBL] [Abstract][Full Text] [Related]
36. Expression of integrin and CD44 adhesion molecules on neuroblastoma: the relation to tumor aggressiveness and embryonic neural-crest differentiation.
Combaret V; Coll JL; Favrot MC
Invasion Metastasis; 1994-1995; 14(1-6):156-63. PubMed ID: 7544774
[TBL] [Abstract][Full Text] [Related]
37. Aiming at neuroblastoma and hitting other worthy targets.
Schor NF
J Child Neurol; 2013 Jun; 28(6):768-73. PubMed ID: 23576410
[TBL] [Abstract][Full Text] [Related]
38. Neural crest-related NXPH1/α-NRXN signaling opposes neuroblastoma malignancy by inhibiting organotropic metastasis.
Fanlo L; Gómez-González S; Rozalén C; Pérez-Núñez I; Sangrador I; Tomás-Daza L; Gautier EL; Usieto S; Rebollo E; Vila-Ubach M; Carcaboso AM; Javierre BM; Celià-Terrassa T; Lavarino C; Martí E; Le Dréau G
Oncogene; 2023 Jul; 42(28):2218-2233. PubMed ID: 37301928
[TBL] [Abstract][Full Text] [Related]
39. Novel Immunotherapeutic Approaches for Neuroblastoma and Malignant Melanoma.
Morandi F; Frassoni F; Ponzoni M; Brignole C
J Immunol Res; 2018; 2018():8097398. PubMed ID: 30510968
[TBL] [Abstract][Full Text] [Related]
40. In situ neuroblastoma: an important concept related to the natural history of neural crest tumors.
Shimada H
Pediatr Dev Pathol; 2005; 8(3):305-6. PubMed ID: 16010489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
